News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
629,547 Results
Type
Article (52050)
Company Profile (261)
Press Release (577236)
Section
Business (174959)
Career Advice (2555)
Deals (31927)
Drug Delivery (106)
Drug Development (77662)
Employer Resources (145)
FDA (16532)
Job Trends (13881)
News (309602)
Policy (31549)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (16)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (1)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (7)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2731)
Academic (1)
Accelerated approval (3)
Adcomms (27)
Allergies (76)
Alliances (47135)
ALS (78)
Alzheimer's disease (1335)
Antibody-drug conjugate (ADC) (95)
Approvals (16503)
Artificial intelligence (215)
Autoimmune disease (12)
Automation (13)
Bankruptcy (339)
Best Places to Work (11175)
BIOSECURE Act (21)
Biosimilars (93)
Biotechnology (185)
Bladder cancer (51)
Brain cancer (26)
Breast cancer (230)
Cancer (1786)
Cardiovascular disease (137)
Career advice (2136)
Career pathing (28)
CAR-T (137)
Cell therapy (384)
Cervical cancer (12)
Clinical research (62621)
Collaboration (707)
Compensation (259)
Complete response letters (25)
COVID-19 (2552)
CRISPR (34)
C-suite (183)
Cystic fibrosis (100)
Data (1687)
Decentralized trials (1)
Denatured (21)
Depression (40)
Diabetes (232)
Diagnostics (5958)
Digital health (18)
Diversity (7)
Diversity, equity & inclusion (35)
Drug discovery (107)
Drug pricing (106)
Drug shortages (27)
Duchenne muscular dystrophy (64)
Earnings (65088)
Editorial (32)
Employer branding (18)
Employer resources (129)
Events (86826)
Executive appointments (592)
FDA (17520)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (634)
Gene editing (88)
Generative AI (22)
Gene therapy (275)
GLP-1 (685)
Government (4080)
Grass and pollen (3)
Guidances (44)
Healthcare (18028)
Huntington's disease (20)
IgA nephropathy (19)
Immunology and inflammation (89)
Indications (23)
Infectious disease (2674)
Inflammatory bowel disease (130)
Inflation Reduction Act (7)
Influenza (39)
Intellectual property (74)
Interviews (482)
IPO (14892)
IRA (41)
Job creations (3182)
Job search strategy (1776)
Kidney cancer (10)
Labor market (20)
Layoffs (397)
Leadership (17)
Legal (7164)
Liver cancer (70)
Lung cancer (253)
Lymphoma (117)
Machine learning (2)
Management (48)
Manufacturing (242)
MASH (56)
Medical device (11955)
Medtech (11960)
Mergers & acquisitions (17423)
Metabolic disorders (596)
Multiple sclerosis (64)
NASH (21)
Neurodegenerative disease (75)
Neuropsychiatric disorders (21)
Neuroscience (1781)
NextGen: Class of 2025 (6200)
Non-profit (4576)
Northern California (1997)
Now hiring (23)
Obesity (326)
Opinion (230)
Ovarian cancer (59)
Pain (77)
Pancreatic cancer (67)
Parkinson's disease (119)
Partnered (18)
Patents (179)
Patient recruitment (82)
Peanut (46)
People (51919)
Pharmaceutical (66)
Pharmacy benefit managers (16)
Phase I (19365)
Phase II (27460)
Phase III (20804)
Pipeline (792)
Podcasts (53)
Policy (109)
Postmarket research (2477)
Preclinical (8241)
Press Release (56)
Prostate cancer (83)
Psychedelics (32)
Radiopharmaceuticals (247)
Rare diseases (346)
Real estate (5075)
Recruiting (63)
Regulatory (22140)
Reports (27)
Research institute (2495)
Resumes & cover letters (421)
Rett syndrome (2)
RNA editing (1)
RSV (37)
Schizophrenia (63)
Series A (110)
Series B (69)
Service/supplier (6)
Sickle cell disease (46)
Southern California (1773)
Special edition (14)
Sponsored (29)
Startups (3308)
State (2)
Stomach cancer (11)
Supply chain (56)
The Weekly (31)
United States (18127)
Vaccines (640)
Venture capitalists (32)
Webinars (9)
Weight loss (229)
Women's health (30)
Worklife (14)
Date
Today (160)
Last 7 days (722)
Last 30 days (2802)
Last 365 days (32768)
2025 (5505)
2024 (33594)
2023 (37757)
2022 (48292)
2021 (52363)
2020 (50943)
2019 (44287)
2018 (33601)
2017 (30771)
2016 (29621)
2015 (34246)
2014 (26912)
2013 (23122)
2012 (24535)
2011 (25100)
2010 (23347)
Location
Africa (833)
Alabama (46)
Alaska (7)
Arizona (146)
Arkansas (12)
Asia (38498)
Australia (6523)
California (4684)
Canada (1661)
China (401)
Colorado (220)
Connecticut (227)
Delaware (110)
Europe (84925)
Florida (707)
Georgia (153)
Idaho (50)
Illinois (449)
India (18)
Indiana (262)
Iowa (5)
Japan (126)
Kansas (92)
Kentucky (21)
Louisiana (10)
Maine (66)
Maryland (704)
Massachusetts (3514)
Michigan (189)
Minnesota (274)
Mississippi (2)
Missouri (75)
Montana (30)
Nebraska (24)
Nevada (50)
New Hampshire (58)
New Jersey (1382)
New Mexico (25)
New York (1375)
North Carolina (868)
North Dakota (8)
Northern California (1997)
Ohio (166)
Oklahoma (14)
Oregon (35)
Pennsylvania (1041)
Puerto Rico (7)
Rhode Island (20)
South America (1125)
South Carolina (14)
South Dakota (1)
Southern California (1773)
Tennessee (77)
Texas (700)
Utah (151)
Virginia (121)
Washington D.C. (56)
Washington State (461)
West Virginia (2)
Wisconsin (43)
629,547 Results for "california institute for regenerative medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine
February 3, 2025
·
8 min read
Press Releases
Entos Pharmaceuticals Awarded $4 Million USD in Funding from the California Institute for Regenerative Medicine (CIRM) for its Congenital Generalized Lipodystrophy Program
February 6, 2025
·
6 min read
Biotech Beach
Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)
Aspen Neuroscience, Inc. has received a CLIN2 grant award of $8 million from the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, to support clinical research aimed at treating Parkinson’s disease (PD).
May 15, 2024
·
4 min read
Biotech Beach
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM) - April 30, 2024
Lineage Cell Therapeutics, Inc. today announced that the Company has received an Education Conference II Grant from the California Institute for Regenerative Medicine (CIRM).
April 30, 2024
·
9 min read
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
Senti Biosciences, Inc., a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, announced that the California Institute for Regenerative Medicines has awarded an $8 million grant to Senti Bio.
July 1, 2024
·
9 min read
BioMidwest
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC)
Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies using its suspension AAV Curator™ Platform under the California Institute for Regenerative Medicine Accelerating Medicines Partnership Bespoke Gene Therapy Consortium.
May 23, 2024
·
3 min read
Press Releases
CIRM Marks 20 Years of Advancing Regenerative Medicine in California
November 15, 2024
·
3 min read
Business
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
Allogene Therapeutics, Inc. announced that it has received a $15 million grant from the California Institute for Regenerative Medicine (CIRM) to support the clinical development of ALLO-316, an AlloCAR T™ investigational product targeting CD70 in development for the treatment of advanced or metastatic renal cell carcinoma (RCC).
April 26, 2024
·
8 min read
Business
Forge Biologics Selected as an AAV Manufacturing Partner for California Institute for Regenerative Medicine to Help Accelerate Gene Therapy Programs
Forge Biologics (Forge), a leading manufacturer of genetic medicines, announced today that it has joined the California Institute for Regenerative Medicine’s (CIRM) Industry Resource Partner Program to help advance the manufacturing of adeno-associated adenovirus (AAV) gene therapy programs from the state of California.
October 11, 2023
·
3 min read
Press Releases
Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.
January 2, 2025
·
6 min read
1 of 62,955
Next
